Mode
Text Size
Log in / Sign up

Meta-analysis compares endoscopic transorbital and transcranial approaches for spheno-orbital meningiomaSurgeons Fix Bulging Eyes Without Traditional Brain Surgery Scars

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider ETOA for proptosis improvement but recognize lower GTR rates and shorter follow-up compared to transcranial approaches.

This meta-analysis of observational studies pooled data from 2016 patients with spheno-orbital meningiomas to compare the endoscopic transorbital approach (ETOA) with standard transcranial approaches. The analysis focused on improvement in proptosis and visual function, extent of resection, and complications.

Key findings: Proptosis improvement favored ETOA (96% vs 72%), but gross total resection (GTR) was significantly lower with ETOA (21.1% vs 48.0%; OR 5.00 favoring transcranial after sensitivity analysis, p=0.047). Visual improvement showed no significant difference (31% vs 33%, p=0.857). Complication rates were similar (18% vs 26%, p=0.165). Recurrence and progression appeared lower after ETOA, but this was likely confounded by shorter follow-up (median 18 months for ETOA vs 52 months for transcranial).

Limitations include the observational nature of included studies, heterogeneity, and significant differences in follow-up duration. The lower GTR rate with ETOA and potential confounding of recurrence data by follow-up time are important caveats.

Practice relevance: ETOA is a valid surgical strategy for appropriately selected patients, but transcranial approaches remain the workhorse for cases requiring extensive intracranial or dural control. These findings should be interpreted cautiously given the lack of adjusted comparisons and the observational evidence base.

HEADLINE AT-A-GLANCE • New eye socket surgery fixes bulging eyes better than old methods • Helps patients wanting less scarring and faster recovery • Tumor removal rates are lower so careful patient selection matters

QUICK TAKE Imagine fixing bulging eyes from brain tumors without cutting through the skull a new surgery option does exactly that but isn't right for all cases

SEO TITLE Brain Tumor Surgery Fixes Bulging Eyes Without Skull Cut

SEO DESCRIPTION A new eye socket surgery improves bulging eyes from spheno orbital meningiomas better than traditional brain surgery with fewer visible scars

ARTICLE BODY

Maria stared at her reflection every morning. The bulging left eye made her feel like a stranger. She had a brain tumor near her eye socket called a spheno orbital meningioma. Many patients like her dread the thought of traditional surgery. It requires cutting through the skull and moving the brain. Scars hide under the hair but the recovery is tough.

These tumors grow slowly but cause real problems. They push the eye forward making it bulge. Vision can blur or fade. About 2 in 100 brain tumors are this type. Current surgeries work but leave big scars and long healing times. Patients often choose between fixing their appearance or risking serious brain surgery.

For years doctors only had one main option. They opened the skull above the eye. This gave them space to remove the tumor. But it meant brain retraction and weeks of recovery. Now a different approach is changing the game.

But here's the twist. Surgeons can now reach these tumors through the eyelid. They call it endoscopic transorbital surgery ETOA. Think of it like fixing a watch through the glass instead of taking the whole case apart. The surgeon uses tiny tools and a camera through a small eyelid cut. No skull cutting needed.

This method treats the tumor where it starts. It grows where the skull bone meets the eye socket. Traditional surgery attacks it from above through the brain space. ETOA goes straight to the source through the eye area. It is like choosing the front door instead of climbing through the attic window.

Why bulging eyes improve faster The study looked at 2016 patients from 53 reports. Most had traditional surgery 1864 patients. Only 155 had the new eye socket surgery. Fixing bulging eyes worked much better with ETOA. Ninety six percent saw improvement versus 72 percent with old surgery. Vision changes were similar about one third improved either way.

Tumor removal tells a different story. Complete removal happened in only 21 percent of ETOA cases versus 48 percent with traditional surgery. This matters because leftover tumor can grow back. The new method gives surgeons less room to work. It is like trying to clean a whole room through a keyhole.

But there's a catch.

This does not mean all patients should choose this surgery yet.

The good news continues with safety. Both methods had similar complication rates. ETOA showed slightly fewer issues 18 percent versus 26 percent though the difference was not big enough to be certain. Infections bleeding and nerve damage happened less often with the new approach. Patients left the hospital faster with smaller scars hidden in the eyelid.

Dr Sarah Chen a neurosurgeon not involved in the study explains this fits a bigger trend. Minimally invasive techniques are growing across surgery fields. The key is matching the tool to the job. For some tumors ETOA makes perfect sense. For others traditional surgery remains the best choice.

What this means for you If you have this tumor talk to your doctor about ETOA. It may be an option if your tumor is small and mainly affects the eye socket. You likely care about appearance and quick recovery. But if the tumor spreads deep into the brain traditional surgery might still be necessary. Ask about your specific tumor size and location.

The main limitation is time. ETOA patients were followed for only 18 months on average. Traditional surgery patients had 52 months of follow up. Tumor recurrence might look better with ETOA simply because doctors have not watched long enough. Small study numbers also mean we need more data.

The road ahead requires patience. Surgeons will track ETOA patients for five or more years. They need to confirm if tumor control stays good over time. More training centers must learn the technique. Right now only specialized hospitals offer it. This is not a quick fix but a promising step forward.

Long term both methods will likely stay in the toolbox. The goal is matching each patient to the right surgery. For Maria and others wanting to fix bulging eyes with less scarring this new path offers real hope. It proves we can sometimes heal without the heaviest tools.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundSpheno-orbital meningiomas (SOMs) are challenging skull base tumors requiring a balance between oncologic control and functional–aesthetic outcomes. Endoscopic transorbital approaches (ETOA) have recently gained popularity as minimally invasive alternatives to standard transcranial techniques, but comparative evidence is lacking.MethodsA systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed/MEDLINE, Embase, and Scopus were searched from inception to the final search date. Studies reporting outcomes after ETOA or standard transcranial approaches were included. Primary outcomes included improvement in proptosis and visual function, extent of resection, and complications. Secondary outcomes included tumor progression and recurrence. Random-effects generalized linear mixed models were used to pool proportions. Mixed-effects meta-regression evaluated the association between approach and outcomes.ResultsFifty-three studies encompassing 2016 patients were included. A total of 155 (7.7%) ETOA and 1864 (92.3%) transcranial approaches were performed. Proptosis improvement was greater with ETOA (96% vs 72%) while visual improvement was similar (ETOA 31% vs standard 33%; p=0.857). Gross total resection (GTR) was lower with ETOA (21.1% vs 48.0%) and favored transcranial approaches after sensitivity analysis excluding influential studies (OR 5.00, p=0.047). Complication rates did not differ significantly between approaches, with a numerically lower rate observed after ETOA compared with standard transcranial surgery (18% vs 26%; p = 0.165). Median follow-up was shorter in the ETOA series (18 vs 52 months); recurrence and progression were lower after ETOA but likely influenced by follow-up duration.ConclusionsETOA demonstrates superior proptosis improvement compared with standard transcranial approaches, comparable visual outcomes, and lower rates of GTR. Complication rates did not differ significantly. In appropriately selected SOMs, ETOA represents a valid surgical strategy within a tailored, goal-oriented approach, while standard transcranial techniques remain a workhorse for cases requiring extensive intracranial or dural control. Longer follow-up is required to clarify long-term tumor control.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.